Alian s.r.o.

At Alian s.r.o. in Bardejov, a major share of the research focuses on cardiovascular diseases, including atrial fibrillation, heart failure, atherosclerotic cardiovascular disease, hypertension, stable angina, and peripheral arterial disease. These studies are designed to test new treatments, reduce major cardiovascular events, and improve long-term disease control.

• Preventing stroke and other complications in atrial fibrillation
• Improving outcomes in heart failure and related cardiac conditions
• Lowering cardiovascular risk in people with established or high-risk disease
• Evaluating therapies for angina, hypertension, and vascular disease

The site is active in both prevention-focused and treatment-focused research, reflecting a broad effort to improve care for people with serious heart and blood vessel conditions.

Research at this hospital/clinic also includes respiratory tract diseases, especially asthma, refractory chronic cough, and respiratory syncytial virus infection. The trials are mainly aimed at testing new inhaled therapies, easing symptoms, and improving day-to-day breathing control.

• Assessing new treatment options for mild to severe asthma
• Studying therapies for chronic cough that remains difficult to control
• Evaluating approaches for people at risk from RSV infection
• Comparing treatments to improve lung function and reduce flare-ups

These studies highlight a strong interest in better symptom relief and more effective management for common and burdensome respiratory conditions.

The site conducts clinical research in digestive system diseases, with a focus on Crohn’s disease and ulcerative colitis. The goal of these trials is to improve control of inflammation, maintain remission, and support better long-term outcomes for people living with inflammatory bowel disease.

• Testing new therapies for moderate to severe inflammatory bowel disease
• Supporting remission maintenance in ulcerative colitis
• Improving symptom control and intestinal healing in Crohn’s disease
• Evaluating longer-term treatment safety and effectiveness

At Alian s.r.o., this area of research is centered on practical advances that may help patients manage chronic gastrointestinal inflammation more successfully.

Clinical trials in immune system diseases at this site include research in chronic spontaneous urticaria and other inflammatory conditions where immune activity plays a central role. These studies are intended to compare treatment options and improve symptom relief for patients whose disease remains difficult to control.

• Evaluating new options for chronic urticaria
• Comparing therapies for patients with inadequate response to standard treatment
• Exploring better ways to control immune-driven symptoms
• Supporting safer and more effective long-term disease management

This research reflects an interest in conditions where the immune system contributes to ongoing discomfort and reduced quality of life.

Another important research area is nutritional and metabolic diseases, including type 2 diabetes, hypertriglyceridemia, and obesity-related metabolic risk. The trials are focused on lowering harmful blood lipids, improving metabolic health, and reducing the chance of future cardiovascular complications.

• Studying treatments for elevated triglycerides and severe hypertriglyceridemia
• Assessing therapies for people with type 2 diabetes and related cardiovascular risk
• Evaluating approaches to weight-related metabolic and heart health problems
• Testing interventions aimed at better long-term risk reduction

These studies connect metabolic care with prevention of broader disease complications, especially in patients who face overlapping heart and metabolic risks.

Skin and connective tissue diseases are represented through research on chronic urticaria, a condition that can cause persistent itching and skin discomfort. The trials at the site are designed to compare therapies and improve control of symptoms in patients who do not respond well to standard care.

• Comparing treatment effectiveness in chronic skin allergy-like conditions
• Improving relief for persistent hives and related symptoms
• Studying new options for patients with limited response to antihistamines
• Supporting more reliable symptom control over time

This area adds a patient-centered dimension to the site’s portfolio, with research aimed at easing daily burden and improving comfort.